Delivery Order SPE2DB22D3401-SPE2DB24FT3YG
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,564,662,850 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $5,905.15 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of 4,567,171,124 units of ondansetron ODT 4 mg tablets in packages of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,811.42, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order with a completion date of February 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award is for the delivery of 4,567,372,778 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,665.15 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 25, 2025, with a completion date of February 26, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $7,427.51 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,995,172 units of the medication Ondansetron ODT 4 mg tablet, with a performance period through April 23, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,565,471,054 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $25,066.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of August 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
The federal contract award is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30 per bottle. The contract, valued at $11,411.24, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,567,227,090 units of 4 mg Ondansetron HCL tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,294.40 firm-fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 11, 2025, with a completion date of February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the purchase of 4,567,175,269 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $12,156.98 firm fixed-price delivery order has a completion date of February 6, 2025 and is not designated under any set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with...